MRI Assessment of Impaired Glucose Metabolism in Alzheimer's Disease
- Conditions
- Alzheimer Disease
- Registration Number
- NCT05402566
- Lead Sponsor
- University of Aarhus
- Brief Summary
Diseases of dementia are chronic, untreatable, and cause a massive burden of morbidity. In this proposal, we seek to tackle the problem of better, earlier, and more efficient diagnosis using deuterium metabolic imaging (DMI). The study is divided in two sub-studies: 1) optimization and simplification of DMI protocols, and 2) a cross-sectional study of DMI in Alzheimer's patients and healthy controls.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 21
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Deuterium Metabolic Imaging Up to 150 mins after 2H-glucose ingestion Lactate/glx ratio in the posterior cingulum (sub-study 2).
- Secondary Outcome Measures
Name Time Method Deuterium Metabolic Imaging Up to 150 mins after 2H-glucose ingestion Simpler DMI quantifications, including reference to external phantoms and internal reference, in the same regions defined in primary outcomes.
Cognitive tests from the records (sub study 2) At time of Deuterium Metabolic Imaging Addenbrooke's Cognitive Examination (0-100, 100 is best)
Cerebrospinal fluid biochemistry from the records (sub study 2) At time of Deuterium Metabolic Imaging Amyloid
FDG-PET from the records (sub study 2) At time of Deuterium Metabolic Imaging Brain glucose uptake
Blood samples Up to 150 mins after 2H-glucose ingestion 2H-enrichment
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Aarhus University
🇩🇰Aarhus, Denmark
Aarhus University🇩🇰Aarhus, Denmark